Latest Breaking News On - Sanjay kalra - Page 1 : comparemela.com

Effect of a multicomponent quality improvement strategy on sustained achievement of diabetes care goals and macrovascular and microvascular complications in South Asia at 6.5 years follow-up: Post hoc analyses of the CARRS randomized clinical trial

Nikhil Tandon and colleagues explore the impact of a quality improvement strategy for patients with type 2 diabetes 6.5 years after its implementation for the CARRS randomised trial.

From our archives: Vineet Nayyar on the remaking of Mahindra Satyam

Vineet Nayyar, as executive vice-chairman of Mahindra Satyam, oversaw the company s overhaul after founder B. Ramalinga Raju confessed to what still is among India s most-alarming financial frauds.Mint is republishing this article from 2009 after Vineet Nayyar passed away on 16 May at the age of 85

Paymentus Holdings, Inc. (NYSE:PAY) Q1 2024 Earnings Call Transcript

Roche Diagnostics India launches heart failure test for diabetics in India

Business News | Roche Diagnostics India's Heart Failure Test for Diabetics Now Available on Its Point-of-care Device

Get latest articles and stories on Business at LatestLY. Mumbai (Maharashtra) [India], April 10: Roche Diagnostics India announces the launch of its point-of-care NT-proBNP test for screening diabetes patients who are at risk of cardiovascular diseases (CVD) such as heart failure (HF). This breakthrough innovation is designed to bring testing closer to clinics and revolutionise patient care. The claim extension of the NT-proBNP biomarker, available exclusively on the cobas® h 232 system, aims to provide faster, more efficient diagnosis and management of HF in patients with type 2 diabetes (T2D). Business News | Roche Diagnostics India's Heart Failure Test for Diabetics Now Available on Its Point-of-care Device.